serenace
aspen pharma pty ltd - haloperidol -
serenace injection
aspen pharma pty ltd - haloperidol -
serenace haloperidol 20 mg/2 ml injection ampoule
aspen pharmacare australia pty ltd - haloperidol, quantity: 10 mg/ml - injection, solution - excipient ingredients: lactic acid; sodium hydroxide; water for injections - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia
serenace unknown 2 mg/ml
norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - unknown - 2 mg/ml
serenace 5 mg/ml ampoule solution for injection.
norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - solution for injection - 5 mg/ml
serenace 2 mg/ml oral solution
norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - oral solution - 2 mg/ml
serenace 5 mg/ml ampoule solution for injection. 5 mg/ml solution for injection
norton healthcare limited t/a ivax pharmaceuticals uk - haloperidol - solution for injection - 5 mg/ml
serenace halperidol 2mg/ml liquid solution
proqualix pty ltd - in administration - haloperidol, quantity: 2 mg/ml - solution - excipient ingredients: lactic acid; methyl hydroxybenzoate; propyl hydroxybenzoate; purified water - anti psychotic